Ann Oncol
- SANTUCCI C, Mignozzi S, Malvezzi M, Boffetta P, et al
European cancer mortality predictions for the year 2024 with focus on colorectal
cancer.
Ann Oncol. 2024 Jan 17:S0923-7534(23)05110-4. doi: 10.1016/j.annonc.2023.
Ann Surg Oncol
- LIN JP, Liu SY, Wang F
ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small
Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062.
- PARK S, Choe J, Lee SM, Choi S, et al
Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The
Prognostic Significance of Delayed Metastasis Diagnosis.
Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984.
Ann Thorac Surg
- STILES BM, Rodriguez-Quintero JH
A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
Ann Thorac Surg. 2024;117:593.
- ALDERETE IS, Nakata K, Hartwig MG
Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small
Cell Lung Cancer.
Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
- PONTULA A, Spies CS, Hartwig MG
Incidentally Found Lung Cancer Following Lung Transplantation: Apples and
Oranges.
Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
BMC Cancer
- CHENG WC, Lin CC, Liao WC, Lin YC, et al
The difference between dacomitinib and afatinib in effectiveness and safety in
first-line treatment of patients with advanced EGFR-mutant non-small cell lung
cancer: a real-world observational study.
BMC Cancer. 2024;24:228.
- LANG Y, Lin Y, Deng M, Liu X, et al
Economic evaluation of cemiplimab plus chemotherapy regimen for advanced
non-small-cell lung cancer.
BMC Cancer. 2024;24:236.
- CHEN HC, Kuo CY, Chang Y, Tsai DL, et al
5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of
proliferation and metastasis for lung cancer cells.
BMC Cancer. 2024;24:248.
BMJ
- HOPKINSON NS
Smoking and lung cancer-70 long years on.
BMJ. 2024;384:q443.
Br J Cancer
- BLECHTER B, Wong JYY, Chien LH, Shiraishi K, et al
Age at lung cancer diagnosis in females versus males who never smoke by race and
ethnicity.
Br J Cancer. 2024 Feb 22. doi: 10.1038/s41416-024-02592.
Cancer
- WEST HJ, Pennell NA
Lessons from ADAURA: Can we improve on a positive trial?
Cancer. 2024;130:659-664.
Cancer Cell
- NABET BY, Hamidi H, Lee MC, Banchereau R, et al
Immune heterogeneity in small-cell lung cancer and vulnerability to immune
checkpoint blockade.
Cancer Cell. 2024 Feb 9:S1535-6108(24)00015-1. doi: 10.1016/j.ccell.2024.
Cancer Chemother Pharmacol
- MA X, Sun Z, Chen H, Cao L, et al
18beta-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting
immune cells from ferroptosis.
Cancer Chemother Pharmacol. 2024 Feb 21. doi: 10.1007/s00280-024-04639.
Cancer Epidemiol Biomarkers Prev
- BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
Association between Airport Ultrafine Particles and Lung Cancer Risk: The
Multiethnic Cohort Study.
Cancer Epidemiol Biomarkers Prev. 2024.
Clin Cancer Res
- WEI D, Wang L, Zuo X, Maitra A, et al
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in
Pancreatic Cancer.
Clin Cancer Res. 2024;30:655-662.
- KASI PM, Lee JK, Pasquina LW, Decker B, et al
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and
Rearrangements Across Cancer Types.
Clin Cancer Res. 2024;30:836-848.
- ZHOU I, Plana D, Palmer AC
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clin Cancer Res. 2024;30:786-792.
Clin Lung Cancer
- MATSUBARA T, Yamaguchi M, Shimokawa M, Okamoto I, et al
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with
Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial.
Clin Lung Cancer. 2024 Jan 28:S1525-7304(24)00010.
- PILON Y, Rokah M, Seitlinger J, Sepesi B, et al
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer:
Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Clin Lung Cancer. 2023 Dec 19:S1525-7304(23)00264.
Clin Nucl Med
- SINGH A, Shah HJ, Dabiri BE, Landman W, et al
Renal Collision Tumor: A Case of Small Cell Lung Cancer Metastasis to Renal
Angiomyolipoma.
Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005136.
Eur J Cancer
- GOMEZ-RANDULFE I, Leporati R, Gupta B, Liu S, et al
Recent advances and future strategies in first-line treatment of ES-SCLC.
Eur J Cancer. 2024;200:113581.
- WANG M, Wang T, Shan J, Sun Y, et al
Alectinib induced vitiligo with rapid re-pigmentation.
Eur J Cancer. 2024;200:113582.
- STRATMANN JA, Althoff FC, Doebel P, Rauh J, et al
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter
real-world experience from the compassionate use program in Germany.
Eur J Cancer. 2024;201:113911.
Eur J Cardiothorac Surg
- SOLDATH P, Binderup T, Kjaer A, Knigge U, et al
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission
tomography mean and maximum standardized uptake values for survival and nodal
involvement in lung neuroendocrine neoplasms.
Eur J Cardiothorac Surg. 2024;65:ezae030.
Hum Pathol
- IVANOVA M, Frascarelli C, Cerbelli B, Pignataro MG, et al
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and
interplatform reproducibility of CE-IVD assays for CPS and IC scores.
Hum Pathol. 2024;144:22-27.
Int J Cancer
- YIN X, Kishida R, Abe SK, Islam MR, et al
Association between reproductive factors with lung cancer incidence and
mortality: A pooled analysis of over 308,000 females in the Asia cohort
consortium.
Int J Cancer. 2024 Feb 20. doi: 10.1002/ijc.34866.
Int J Oncol
- XIE L, Xie D, Du Z, Xue S, et al
A novel therapeutic outlook: Classification, applications and challenges of
inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
Int J Oncol. 2024;64:38.
Int J Radiat Oncol Biol Phys
- WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation
for Locally-Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
- BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional
Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
J Cancer Res Clin Oncol
- KRIZOVA L, Benesova I, Zemanova P, Spacek J, et al
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders
to immune checkpoint inhibitors.
J Cancer Res Clin Oncol. 2024;150:99.
- WANG Y, Dong A, Jin M, Li S, et al
TEP RNA: a new frontier for early diagnosis of NSCLC.
J Cancer Res Clin Oncol. 2024;150:97.
- NIU L, Wu H, Gao R, Chen L, et al
Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative
study of first-line EGFR-TKIs with/without upfront LT.
J Cancer Res Clin Oncol. 2024;150:94.
Lung Cancer
- LAESEKE P, Ng C, Naghi A, Wright GWJ, et al
Response to letter: Microwave ablation for Early-Stage Non-Small cell Lung
Cancer: Don't Put the Cart before the stereotactic Horse.
Lung Cancer. 2024;189:107504.
- SAAL J, Bald T, Eckstein M, Ralser DJ, et al
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve
imaging-based prediction of outcomes in patients with non-small cell lung cancer
on immune checkpoint inhibition.
Lung Cancer. 2024;189:107505.
Oncologist
- BRIA E, Morgillo F, Garassino MC, Ciardiello F, et al
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated
Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb
Trial.
Oncologist. 2024 Feb 20:oyad342. doi: 10.1093.
PLoS Genet
- KHOUJA JN, Sanderson E, Wootton RE, Taylor AE, et al
Estimating the health impact of nicotine exposure by dissecting the effects of
nicotine versus non-nicotine constituents of tobacco smoke: A multivariable
Mendelian randomisation study.
PLoS Genet. 2024;20:e1011157.
PLoS One
- CHEN Q, Li W, Cai N, Chen W, et al
Comparison of postoperative complications in mediastinal lymph node dissection
versus mediastinal lymph node sampling for early stage non-small cell lung
cancer: Protocol for a systematic review and meta-analysis.
PLoS One. 2024;19:e0298368.
Proc Natl Acad Sci U S A
- JANSEN RA, Mainardi S, Dias MH, Bosma A, et al
Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
KRAS-mutant cancers.
Proc Natl Acad Sci U S A. 2024;121:e2319492121.
Science
- KRISHNA C, Tervi A, Saffern M, Wilson EA, et al
An immunogenetic basis for lung cancer risk.
Science. 2024;383:eadi3808.
Thorax
- KOO MM, Mounce LTA, Rafiq M, Callister MEJ, et al
Guideline concordance for timely chest imaging after new presentations of
dyspnoea or haemoptysis in primary care: a retrospective cohort study.
Thorax. 2024;79:236-244.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016